MedPath

Coronary Artery Study in Pediatric Heart Transplantation

Withdrawn
Conditions
Transplant Coronary Artery Disease
Registration Number
NCT01546870
Lead Sponsor
Arkansas Children's Hospital Research Institute
Brief Summary

Transplant coronary artery disease (TCAD) is a significant cause of morbidity and mortality in pediatric heart transplantation (PHT). Understanding the pathophysiology and early detection along with attempted medical management are crucial in preventing advancement of the disease and retransplantation or mortality. Coronary angiogram, although routinely used is insensitive to detect early TCAD. Measurement of fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microvascular resistance (IMR) using a doppler pressure and flow intracoronary wire may be more sensitive in evaluating the integrity of coronary vasculature and thus detect pre clinical TCAD. To the best of the investigators knowledge, measurement of these parameters has not been previously reported in PHT.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • less than 21 years and above 7 years of age
Exclusion Criteria
  • clinically significant coronary artery disease on angiography and inability to undergo IVUS

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical coronary artery disease1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Arkansas Children's hospital

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath